Market Cap 106,000.00
Revenue (ttm) 0.00
Net Income (ttm) -24.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 48,500
Avg Vol 462,220
Day's Range N/A - N/A
Shares Out 30,000.00
Stochastic %K 25%
Beta 1.51
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
TheFieldBreaks
TheFieldBreaks Nov. 15 at 4:42 AM
Check Fintel. Jane Street, UBS Group, Morgan Stanley, Tower Research etc are in, all within the last week. That doesn't guarantee an immediate increase in volume or appreciation of the stock price but it does signal growing institutional interest in the company. It's a good sign. $NCNA
0 · Reply
Spc_baller
Spc_baller Nov. 15 at 2:01 AM
0 · Reply
TVanda00
TVanda00 Nov. 15 at 1:05 AM
$NCNA https://www.fiercebiotech.com/biotech/evaxion-offloads-vaccine-candidate-merck-592-million-biobucks
3 · Reply
cycloon
cycloon Nov. 14 at 7:15 PM
0 · Reply
HLucasH
HLucasH Nov. 14 at 7:10 PM
$NCNA 😂😂😂😂
0 · Reply
Benja69
Benja69 Nov. 14 at 4:22 PM
0 · Reply
GreenEnergy1
GreenEnergy1 Nov. 14 at 3:33 PM
0 · Reply
TVanda00
TVanda00 Nov. 14 at 2:52 PM
0 · Reply
stwix
stwix Nov. 14 at 2:08 PM
$NCNA Merck's Keytruda patent will expire in 2028. Currently they do their best to find revenue sources and diversify for the coming years, like with recently announced buyout of Cidara Therapeutics - CDTX (antiviral drug). A well working patented KeyTruda booster (NUC-7738 / NUC-3373) looks a perfect match to me for a company who knows KeyTruda from the inside out.
2 · Reply
ChickenClaw
ChickenClaw Nov. 14 at 1:38 PM
$NCNA MERCK Getting Frisky...Is There More To Follow In The Sector?
0 · Reply
Latest News on NCNA
NuCana Compliant with All Nasdaq Continued Listing Criteria

Sep 5, 2025, 8:00 AM EDT - 2 months ago

NuCana Compliant with All Nasdaq Continued Listing Criteria


NuCana Announces ADS Ratio Change

Aug 1, 2025, 4:05 PM EDT - 3 months ago

NuCana Announces ADS Ratio Change


NuCana Announces Plan to Implement ADS Ratio Change

Jul 11, 2025, 10:30 AM EDT - 4 months ago

NuCana Announces Plan to Implement ADS Ratio Change


Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Feb 10, 2025, 7:00 AM EST - 9 months ago

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer


Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 1 year ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares


NuCana: Potential Turnaround In 2024 But Risky

Jan 3, 2024, 2:39 AM EST - 2 years ago

NuCana: Potential Turnaround In 2024 But Risky


NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Listing Transfer to Nasdaq Capital Market


NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 2 years ago

NuCana to Present at the Jefferies Healthcare Conference


NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 2 years ago

NuCana Announces Receipt of Nasdaq Notice


NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 2 years ago

NuCana to Participate in Two Upcoming Investor Conferences


NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Receipt of NASDAQ Notice


NuCana: An Intriguing 'Sum Of The Parts' Story

Sep 22, 2022, 3:40 PM EDT - 3 years ago

NuCana: An Intriguing 'Sum Of The Parts' Story


TheFieldBreaks
TheFieldBreaks Nov. 15 at 4:42 AM
Check Fintel. Jane Street, UBS Group, Morgan Stanley, Tower Research etc are in, all within the last week. That doesn't guarantee an immediate increase in volume or appreciation of the stock price but it does signal growing institutional interest in the company. It's a good sign. $NCNA
0 · Reply
Spc_baller
Spc_baller Nov. 15 at 2:01 AM
0 · Reply
TVanda00
TVanda00 Nov. 15 at 1:05 AM
$NCNA https://www.fiercebiotech.com/biotech/evaxion-offloads-vaccine-candidate-merck-592-million-biobucks
3 · Reply
cycloon
cycloon Nov. 14 at 7:15 PM
0 · Reply
HLucasH
HLucasH Nov. 14 at 7:10 PM
$NCNA 😂😂😂😂
0 · Reply
Benja69
Benja69 Nov. 14 at 4:22 PM
0 · Reply
GreenEnergy1
GreenEnergy1 Nov. 14 at 3:33 PM
0 · Reply
TVanda00
TVanda00 Nov. 14 at 2:52 PM
0 · Reply
stwix
stwix Nov. 14 at 2:08 PM
$NCNA Merck's Keytruda patent will expire in 2028. Currently they do their best to find revenue sources and diversify for the coming years, like with recently announced buyout of Cidara Therapeutics - CDTX (antiviral drug). A well working patented KeyTruda booster (NUC-7738 / NUC-3373) looks a perfect match to me for a company who knows KeyTruda from the inside out.
2 · Reply
ChickenClaw
ChickenClaw Nov. 14 at 1:38 PM
$NCNA MERCK Getting Frisky...Is There More To Follow In The Sector?
0 · Reply
vestedholdings
vestedholdings Nov. 14 at 1:23 PM
$NCNA 3rd Quarter 2025 financial results and business update. https://www.crweworld.com/article/news-provided-by-globenewswire/3747379/nucana-reports-third-quarter-2025-financial-results-and-provides-business-update
0 · Reply
TVanda00
TVanda00 Nov. 14 at 1:20 PM
$NCNA I dont think a good data readout in Q4 will push price past Octobers high.
2 · Reply
ChickenClaw
ChickenClaw Nov. 14 at 12:41 PM
$NCNA Merger/Buyout Potential Greatly Goes Up With Latest News.
1 · Reply
ChickenClaw
ChickenClaw Nov. 14 at 12:38 PM
$NCNA Plus Good News Being Released...All Timing.
0 · Reply
TVanda00
TVanda00 Nov. 14 at 12:35 PM
$NCNA Last months spinning top candle I that I keep mentioning. Not a good look for the short to medium timeframe.
0 · Reply
ChickenClaw
ChickenClaw Nov. 14 at 12:34 PM
$NCNA BULLISH Double Bottom Forming On Day Chart>
0 · Reply
GuineaPigForever
GuineaPigForever Nov. 14 at 12:13 PM
$NCNA 3 hours into premarket and I am seeing 22 shares traded?
1 · Reply
piotrek123082
piotrek123082 Nov. 14 at 11:58 AM
$NCNA Thats what you say to yourself every morning you get up and look in the mirrow
0 · Reply
piotrek123082
piotrek123082 Nov. 14 at 11:55 AM
0 · Reply
piotrek123082
piotrek123082 Nov. 14 at 11:54 AM
0 · Reply
TVanda00
TVanda00 Nov. 14 at 11:46 AM
$NCNA New ATLs wouldnt surprise me
1 · Reply
TopRunners
TopRunners Nov. 14 at 11:06 AM
What is happening to ticker ARBB ?! Looks like they are going to Squeeze ticker ARBB up .. ARBB is starting to breakout! Are they pumping up ticker ARBB for 300% today!? Its insane what's going on in this market.. Looks like all eyes are going to ARBB now.. Trending #1 Watching: $HUSA $ALZN $HUBC $NCNA ....
0 · Reply